Question 1

What is Jublia?

Accepted Answer

Jublia is an antifungal medication that contains the active ingredient efinaconazole. It functions by stopping the growth of certain types of fungus that can affect the toenails.

As a member of the azole antifungal class, this medication is designed to target the underlying cause of fungal toenail issues. It is used to help clear the infection and allow for the growth of a new nail.

Question 2

What is Jublia used for?

Accepted Answer

Jublia is used to treat onychomycosis of the toenail.

Question 3

How does Jublia work?

Accepted Answer

Mechanism of Action

Jublia contains efinaconazole, which belongs to a group of medicines called azole antifungals. It is designed to treat fungal infections of the toenails by targeting the specific biological processes the fungus needs to survive and grow.

How It Targets Fungus

The medication works by blocking the production of ergosterol, a vital component of the fungal cell membrane. Ergosterol acts similarly to cholesterol in humans, providing structure and integrity to the cell. Without enough ergosterol, the cell membrane becomes weak and develops holes, causing the fungal cell to break down and die.

Reaching the Infection

Because fungal infections often live deep within or under the nail, Jublia is formulated to penetrate the hard surface of the toenail. This allows the medicine to reach the nail bed where the infection is located. Key aspects of how it works include:

Inhibition: It stops the specific enzyme responsible for building the fungal cell wall.

Penetration: The solution is designed to pass through the nail plate to reach the site of the infection.

Growth: By stopping the spread of the fungus, it allows a new, healthy nail to grow in over time to replace the infected nail.

Question 4

What are the active ingredients in Jublia?

Accepted Answer

The active ingredient in Jublia is efinaconazole .

Question 5

What are the side effects of Jublia?

Accepted Answer

Common side effects of Jublia may include:

application site dermatitis

ingrown toenail

application site pain

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Jublia?

Accepted Answer

Jublia belongs to the antifungal drug class.

Question 7

What is the dosage of Jublia and how do I take it?

Accepted Answer

How to Apply

Jublia is for use on the toenails and the surrounding skin only. It should not be used in the eyes, mouth, or vagina. Follow these general steps for application:

Clean and dry the toenails before use. It is recommended to wait a short period after showering or bathing before applying the medication.

Apply the solution once daily to the affected toenails using the integrated brush applicator.

Apply the medication to the entire toenail surface, the skin folds around the sides of the nail, the cuticle, and the area underneath the tip of the nail.

Allow the treated area to dry completely before covering the feet with socks or shoes.

Missed Dose

If a dose is missed, apply it as soon as you remember. If it is almost time for the next scheduled application, skip the missed dose and continue with the regular daily routine. Do not apply extra medication to make up for a missed dose.

Important Considerations

Treatment typically continues for several months to achieve results. Avoid using nail polish or other cosmetic nail products on the toenails being treated with this medication. Wash your hands with soap and water after applying the solution.

Question 8

Is Jublia safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies on the use of Jublia (efinaconazole) in pregnant women. In animal reproduction studies, high oral doses of efinaconazole were associated with developmental toxicity. However, the amount of medication absorbed into the bloodstream after topical application to the nails is very low in humans, which may limit the risk to a developing fetus. Because human data is unavailable, Jublia should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is not known whether efinaconazole is excreted in human milk or if it has any effects on the breastfed infant or milk production. Because systemic absorption of the drug is minimal following topical application, the risk of significant exposure to a nursing infant is expected to be low. Patients should discuss the use of this medication with a healthcare provider to determine the most appropriate course of action while breastfeeding.

Question 9

What forms and strengths does Jublia come in?

Accepted Answer

Available Forms

Jublia is supplied as a topical solution. It is a clear, colorless to pale yellow liquid intended for application to the toenails and the skin immediately surrounding the nail. It is not for use in the eyes, mouth, or vagina.

Strengths

This medication is available in the following strength:

Topical solution: 10%

The solution is typically packaged in plastic squeeze bottles that feature an integrated brush applicator to help apply the medication to the affected area.

Question 10

What is the FDA approval status of Jublia?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) first approved Jublia (efinaconazole) topical solution, 10% in June 2014. It was the first triazole antifungal approved for the topical treatment of toenail fungus.

Approved Indications

Jublia is indicated for the topical treatment of onychomycosis of the toenails caused by specific fungi, including:

Trichophyton rubrum

Trichophyton mentagrophytes

Initially approved for use in adults, the FDA expanded the approved indication in 2020 to include pediatric patients 6 years of age and older.

Regulatory Status and Safety

Jublia is available only by prescription. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with its use. The FDA has not issued any major safety communications or recalls for this medication since its initial approval.

Generic Availability

While the FDA has approved generic versions of efinaconazole topical solution, 10%, they may not be immediately available in all pharmacies due to patent protections and legal considerations. Currently, the medication is primarily available as the brand-name product Jublia.

Question 11

What should I know about Jublia and cost?

Accepted Answer

Generic Availability

Jublia is currently available only as a brand-name medication. There is no FDA-approved generic version of efinaconazole topical solution at this time. Because brand-name drugs are protected by patents, generic alternatives are not expected to be available for several years, which typically keeps the retail price higher.

Insurance Coverage

Insurance plans vary in how they cover Jublia. Some insurance providers may classify it as a non-preferred drug, which can lead to higher co-pays. In some instances, insurance companies may require prior authorization or step therapy, where a patient must try less expensive antifungal treatments before the plan will cover Jublia.

Factors Influencing Price

The out-of-pocket cost for Jublia depends on several factors, including:

The specific pharmacy and its location.

The size of the bottle prescribed (typically 4 mL or 8 mL).

Whether the patient is eligible for manufacturer savings cards or patient assistance programs.

The details of an individual's prescription drug coverage or deductible status.

Patients without insurance or those with high-deductible plans may find the retail price to be substantial. Comparing prices at different pharmacies and checking for manufacturer-sponsored discounts may help manage these costs.

Jublia

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?